Citation Impact
Citing Papers
Relationship of Brain-Derived Neurotrophic Factor and Its Receptor TrkB to Altered Inhibitory Prefrontal Circuitry in Schizophrenia
2005
Genetic Influences on Brain Gene Expression in Rats Selected for Tameness and Aggression
2014 StandoutNobel
MRNA expression patterns and distribution of white matter neurons in dorsolateral prefrontal cortex of depressed patients differ from those in schizophrenia patients
2002
Molecular abnormalities in the major psychiatric illnesses: Classification and Regression Tree (CRT) analysis of post-mortem prefrontal markers
2002
The neuropathology of autism: defects of neurogenesis and neuronal migration, and dysplastic changes
2010
Reciprocal Alterations in Pre- and Postsynaptic Inhibitory Markers at Chandelier Cell Inputs to Pyramidal Neurons in Schizophrenia
2002
The Human Brain Revisited Opportunities and Challenges in Postmortem Studies of Psychiatric Disorders
2002
GAD1 (2q31.1), which encodes glutamic acid decarboxylase (GAD67), is associated with childhood-onset schizophrenia and cortical gray matter volume loss
2004
Prenatal viral infection in mouse causes differential expression of genes in brains of mouse progeny: A potential animal model for schizophrenia and autism
2005
RIM1α and Interacting Proteins Involved in Presynaptic Plasticity Mediate Prepulse Inhibition and Additional Behaviors Linked to Schizophrenia
2010 StandoutNobel
Interstitial white matter neurons express less reelin and are abnormally distributed in schizophrenia: towards an integration of molecular and morphologic aspects of the neurodevelopmental hypothesis
2003
Increased Vulnerability to Depressive-Like Behavior of Mice with Decreased Expression of VGLUT1
2009
Region‐specific deletions of RIM1 reproduce a subset of global RIM1α−/− phenotypes
2011 StandoutNobel
Microarray reality checks in the context of a complex disease
2004
Decreased Thalamic Expression of the Homeobox Gene DLX1 in Psychosis
2003
Neuroplasticity of Neocortical Circuits in Schizophrenia
2007
Molecular and cellular mechanisms of altered GAD1/GAD67 expression in schizophrenia and related disorders
2006
GABAergic Interneurons Implications for Understanding Schizophrenia and Bipolar Disorder
2001
Maternal Immune Activation Alters Fetal Brain Development through Interleukin-6
2007 Standout
Mechanisms and Functional Implications of Adult Neurogenesis
2008 Standout
Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse
2009 Standout
Transgender people: health at the margins of society
2016 Standout
Deletion of α‐neurexins does not cause a major impairment of axonal pathfinding or synapse formation
2007 StandoutNobel
The Cytotoxicity of Tumor Necrosis Factor Depends on Induction of the Mitochondrial Permeability Transition
1996
Schizophrenia, vitamin D, and brain development
2004
The role of autophagy in neurodegenerative disease
2013 Standout
Converging Evidence of NMDA Receptor Hypofunction in the Pathophysiology of Schizophrenia
2003
Glutamate decarboxylase65-immunoreactive terminals in cingulate and prefrontal cortices of schizophrenic and bipolar brain
2000
Neural Synchrony in Brain Disorders: Relevance for Cognitive Dysfunctions and Pathophysiology
2006 Standout
Neurexins Physically and Functionally Interact with GABAA Receptors
2010 StandoutNobel
Design, synthesis, and structure–activity relationships of novel tetracyclic compounds as peripheral benzodiazepine receptor ligands
2004
Dendritic Spine Hypoplasticity and Downregulation of Reelin and GABAergic Tone in Schizophrenia Vulnerability
2001
Translocator protein (18kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function
2006
Complexin 1 knockout mice exhibit marked deficits in social behaviours but appear to be cognitively normal
2007
The peripheral-type benzodiazepine receptor and the cardiovascular system. Implications for drug development
2005
Maternal and child undernutrition and overweight in low-income and middle-income countries
2013 Standout
The axonal chemorepellant semaphorin 3A is increased in the cerebellum in schizophrenia and may contribute to its synaptic pathology
2003
Selective alterations in prefrontal cortical GABA neurotransmission in schizophrenia: a novel target for the treatment of working memory dysfunction
2003
Synapse Loss and Microglial Activation Precede Tangles in a P301S Tauopathy Mouse Model
2007 Standout
Knockdown of DISC1 by In Utero Gene Transfer Disturbs Postnatal Dopaminergic Maturation in the Frontal Cortex and Leads to Adult Behavioral Deficits
2010
White Matter Changes in Schizophrenia
2003
Density and distribution of white matter neurons in schizophrenia, bipolar disorder and major depressive disorder: no evidence for abnormalities of neuronal migration
2002
[11C]DAA1106: radiosynthesis and in vivo binding to peripheral benzodiazepine receptors in mouse brain
2003
Peripheral-type benzodiazepine receptor density and in vitro tumorigenicity of glioma cell lines
2004
Targeted Disruption of the Nuclear Receptor FXR/BAR Impairs Bile Acid and Lipid Homeostasis
2000 Standout
GABAA Receptor Downregulation in Brains of Subjects with Autism
2008
Cancer genes and the pathways they control
2004 Standout
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
2013 Standout
Autism-Associated Neuroligin-3 Mutations Commonly Disrupt Tonic Endocannabinoid Signaling
2013 StandoutNobel
Reelin Regulates Neuronal Progenitor Migration in Intact and Epileptic Hippocampus
2007
Decreased expression of vesicular glutamate transporter 1 and complexin II mRNAs in schizophrenia: further evidence for a synaptic pathology affecting glutamate neurons
2004
Novelty and Anxiolytic Drugs Dissociate Two Components of Hippocampal Theta in Behaving Rats
2013 StandoutNobel
Patches of Disorganization in the Neocortex of Children with Autism
2014 Standout
Protracted Developmental Trajectories of GABAA Receptor α1 and α2 Subunit Expression in Primate Prefrontal Cortex
2009
The cell biology of neurogenesis
2005 Standout
Bipolar Disorder
2004
Stress signalling pathways that impair prefrontal cortex structure and function
2009 Standout
Neocortical excitation/inhibition balance in information processing and social dysfunction
2011 StandoutNature
Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia
2008
Gene expression in dopamine and GABA systems in an animal model of schizophrenia: effects of antipsychotic drugs
2003
The Peripheral Benzodiazepine Receptors: A Review
2000
Catching Up on Schizophrenia
2000
Visualizing Sexual Dimorphism in the Brain
2004 StandoutNobel
Rethinking schizophrenia
2010 StandoutNature
Disrupted in Schizophrenia 1 and Nudel form a neurodevelopmentally regulated protein complex: implications for schizophrenia and other major neurological disorders
2003
Effects of a mediodorsal thalamus lesion on prefrontal inhibitory circuitry: implications for schizophrenia
2003
Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals
2003 Standout
GABA Transporter-1 mRNA in the Prefrontal Cortex in Schizophrenia: Decreased Expression in a Subset of Neurons
2001
Adult Neurogenesis in the Mammalian Brain: Significant Answers and Significant Questions
2011 Standout
Neuroligin-1 Deletion Results in Impaired Spatial Memory and Increased Repetitive Behavior
2010 StandoutNobel
Mitochondrial Membrane Permeabilization in Cell Death
2007 Standout
Extracellular Matrix: Functions in the Nervous System
2010
DISC1 immunoreactivity at the light and ultrastructural level in the human neocortex
2006
Membrane lipids: where they are and how they behave
2008 Standout
Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence
2004 Standout
Mouse models of autism spectrum disorders: The challenge for behavioral genetics
2006
Major Depressive Disorder
2008 Standout
Hypomethylation of MB-COMT promoter is a major risk factor for schizophrenia and bipolar disorder
2006
Density of Glutamic Acid Decarboxylase 67 Messenger RNA–ContainingNeurons That Express the N-Methyl-D-AspartateReceptor Subunit NR2A in the Anterior Cingulate Cortex in Schizophreniaand Bipolar Disorder
2004
Reversing the direction in a light-driven rotary molecular motor
2010 StandoutNobel
Selective deficits in prefrontal cortical GABAergic neurons in schizophrenia defined by the presence of calcium-binding proteins
2002
A Novel Cytochrome P450 Expressed Primarily in Brain
1995
Glucocorticoid interaction with aggression in non-mammalian vertebrates: Reciprocal action
2005
The Endophenotype Concept in Psychiatry: Etymology and Strategic Intentions
2003 Standout
GABAergic dysfunction in mood disorders
2003
Sexually dimorphic gene expression in mouse brain precedes gonadal differentiation
2003
The neuropathology of primary mood disorder
2002
The GABAergic system in schizophrenia
2002
The molecular neurobiology of depression
2008 StandoutNature
Parvalbumin neurons and gamma rhythms enhance cortical circuit performance
2009 StandoutNature
The Overexpression of Bax Produces Cell Death upon Induction of the Mitochondrial Permeability Transition
1998 Standout
Conserved Regional Patterns of GABA-Related Transcript Expression in the Neocortex of Subjects With Schizophrenia
2008
NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease
2013 Standout
Differential Hippocampal Expression of Glutamic Acid Decarboxylase 65 and 67 Messenger RNA in Bipolar Disorder and Schizophrenia
2002
Atroposelective Total Synthesis of Axially Chiral Biaryl Natural Products
2010 Standout
Lipoprotein Receptors in the Nervous System
2002
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
2016 Standout
Altered cortical glutamatergic and GABAergic signal transmission with glial involvement in depression
2005
The Enzymes, Regulation, and Genetics of Bile Acid Synthesis
2003 Standout
Effects of centrally administered anxiolytic compounds in animal models of anxiety
1999
Cortical inhibitory neurons and schizophrenia
2005 Standout
Signals for Sorting of Transmembrane Proteins to Endosomes and Lysosomes
2003 Standout
Review: Glutamate and dopamine dysregulation in schizophrenia — a synthesis and selective review
2007
Disrupted-in-Schizophrenia-1 (DISC-1): Mutant truncation prevents binding to NudE-like (NUDEL) and inhibits neurite outgrowth
2002
Interstitial white matter neurons express less reelin and are abnormally distributed in schizophrenia: towards an integration of molecular and morphologic aspects of the neurodevelopmental hypothesis
2003
The neuroanatomy of schizophrenia: circuitry and neurotransmitter systems
2003
The Release of Cytochrome c from Mitochondria: A Primary Site for Bcl-2 Regulation of Apoptosis
1997 StandoutScience
Gene Expression Deficits in a Subclass of GABA Neurons in the Prefrontal Cortex of Subjects with Schizophrenia
2003
Reactions of Hydrosilanes with Transition-Metal Complexes: Formation of Stable Transition-Metal Silyl Compounds
1998
Reelin Signals through Phosphatidylinositol 3-Kinase and Akt To Control Cortical Development and through mTor To Regulate Dendritic Growth
2007
Magnetically Recoverable Nanocatalysts
2011 Standout
Reelin promoter hypermethylation in schizophrenia
2005
Genetic Architecture of Tameness in a Rat Model of Animal Domestication
2009 StandoutNobel
Visible‐Light Photocatalysis: Does It Make a Difference in Organic Synthesis?
2018 Standout
Transcriptomes of germinal zones of human and mouse fetal neocortex suggest a role of extracellular matrix in progenitor self-renewal
2012 StandoutNobel
Tandem cyclisation of vinyl radicals: a sustainable approach to indolines utilizing visible-light photoredox catalysis
2017
Application of the Palladium-Catalyzed Borylation/Suzuki Coupling (BSC) Reaction to the Synthesis of Biologically Active Biaryl Lactams
2002
N-Heterocyclic Carbene Analogues with Low-Valent Group 13 and Group 14 Elements: Syntheses, Structures, and Reactivities of a New Generation of Multitalented Ligands
2010 Standout
Schizophrenia as a Disorder of Neurodevelopment
2002
Do NMDA receptor antagonist models of schizophrenia predict the clinical efficacy of antipsychotic drugs?
2007
Postnatal development of pre‐ and postsynaptic GABA markers at chandelier cell connections with pyramidal neurons in monkey prefrontal cortex
2003
Mouse neurexin-1α deletion causes correlated electrophysiological and behavioral changes consistent with cognitive impairments
2009 StandoutNobel
An epigenetic mouse model for molecular and behavioral neuropathologies related to schizophrenia vulnerability
2002
Works of James Auta being referenced
Decrease in Reelin and Glutamic Acid Decarboxylase67 (GAD67) Expression in Schizophrenia and Bipolar Disorder
2000
GABAA receptors and benzodiazepines: a role for dendritic resident subunit mRNAs11This paper is part of a previously published Special Issue (Volume 43/4) that accompanies the 12th Neuropharmacology Conference 2002 entitled ‘GABAA receptors in cellular and network excitability’.
2002
GABAergic dysfunction in schizophrenia: new treatment strategies on the horizon
2005
The pharmacology of neurosteroidogenesis
1994
Participation of mitochondrial diazepam binding inhibitor receptors in the anticonflict, antineophobic and anticonvulsant action of 2-aryl-3-indoleacetamide and imidazopyridine derivatives.
1993
223. Reelin and GAD67 downregulation and psychosis vulnerability
2000
Synthesis of (2‐Arylindol‐3‐yl)acetamides as Probes of Mitochondrial Steroidogenesis—A New Mechanism for GABAA Receptor Modulation
1992
Reelin secretion from glutamatergic neurons in culture is independent from neurotransmitter regulation
2000
2-Aryl-3-indoleacetamides (FGIN-1): a new class of potent and specific ligands for the mitochondrial DBI receptor (MDR).
1992
Down-regulation of dendritic spine and glutamic acid decarboxylase 67 expressions in the reelin haploinsufficient heterozygous reeler mouse
2001
Expression of reelin in adult mammalian blood, liver, pituitary pars intermedia, and adrenal chromaffin cells
2000
A search for a new anticonvulsant and anxiolytic benzodiazepine devoid of side effects and tolerance liability.
1995